[1]
T. I. Ivko and T. A. Germanyuk, “Determination of the cost-effective advantages of regimens of diabetes mellitus type 2 with modern DPP-4 inhibitors”, Farm Zh, no. 6, pp. 29-34, Feb. 2019.